Navigation Links
Specialist Eric R. Braverman, MD Discusses Dementia Prevention With Presidential Hopeful Hillary Clinton
Date:1/12/2016

Democratic presidential candidate Hillary Clinton’s has stated her commitment to dramatically increase funding of Alzheimer’s disease research with the goal to find a cure by the year 2025. New York-based Eric R. Braverman, MD, with 25 years of experience in the areas of dementia and Alzheimer’s disease and considered a guru in the field, proposes that there should be allocation of significant funds toward identifying the disease’s early stages. He encourages universal BEAM (Brain Electrical Activity Map) tests for detection, which can be easily administered in a primary care physician’s office. As a post-grad at Harvard, he was involved in the research and development of the test and has seen its ability to help to diagnose the likelihood of the disease based on the progression of Mild Cognitive Impairment.

Read the full story at http://www.prweb.com/releases/2016/01/prweb13160280.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. Colorado Knee Specialist Robert LaPrade, MD Publishes New Studies Covering the Function of the Posterior Cruciate Ligament (PCL) and Treatments for PCL Injuries
2. Colorado Shoulder Specialist Dr. Peter J. Millett Selected as an Honorary Member of the German Arthroscopy Association (AGA)
3. Burlington, VT Sciatica And Back Pain Specialist Offers New Treatment Programs For Chronic And Severe Pain Sufferers
4. Washington University and Barnes-Jewish Heart Specialists Hold CME Event: Top Advancements in the Treatment of Structural Heart Disease
5. Blacks have less access to cancer specialists, treatment
6. Atlantic NeuroSurgical Specialists (ANS) Eradicates Common Misconceptions About Neurosurgery
7. OhioHealth Welcomes New Foot and Ankle Specialist
8. NHVS – Novant Vein Health Specialists Publishes New Article About What Bulging Veins Could Mean About Your Vascular Health
9. Washington University and Barnes-Jewish Heart Specialists First in Missouri to Implant Subcutaneous ICD
10. Novant Health Vein Specialists Publishes New Article Encouraging Prompt Vein Disease Treatment
11. Yael Fuchs, MD, FACOG, of Gramercy Gynecological Health, PLLC, Receives InTone® Specialist Certification To Help Women Stop Bladder Leakage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... Philadelphia, PA (PRWEB) , ... June 28, 2017 ... ... will host a one-day corporate governance program for mid-market executives as a kick-off ... will be held Sunday, Sept. 24, 2017 on the University of Pennsylvania campus, ...
(Date:6/28/2017)... Vancouver, British Columbia (PRWEB) , ... June 28, ... ... (OTCQB: CNZCF) (FSE: ZEON) is pleased to announce that a two year study ... using the Company's Bromley Creek zeolite was successful in remediating potash brine-impacted groundwater. ...
(Date:6/28/2017)... ... June 28, 2017 , ... Designers ... to communities in northern Virginia and DC, is announcing a cooperative charity event ... with Alzheimer’s and other disorders that lead to memory impairment. , The Insight ...
(Date:6/27/2017)... Rolling Meadows, IL (PRWEB) , ... June 27, ... ... they are considering a cosmetic treatment, according to survey data released today by ... Consumer Survey on Cosmetic Dermatologic Procedures indicates the percentage of consumers considering ...
(Date:6/27/2017)... ... 2017 , ... Salucro, the cloud-based payment platform that has ... and provider groups, has announced that it will now offer Parasail’s payment plans ... San Francisco health-finance startup that has launched a series of tech-based products that ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... , June 14, 2017 The Bio Supply ... City of Fremont and the Biomedical ... bio-pharma industry in California by ... executive networking, and fostering workforce development. The primary focus ... growth of start-ups, as well as small and mid-sized ...
(Date:6/11/2017)... 2017  Eli Lilly and Company (NYSE: LLY ... studies of galcanezumab, an investigational treatment for the prevention ... several key secondary endpoints for galcanezumab compared to placebo ... (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today at ... Boston . "The ...
(Date:6/8/2017)... , June 8, 2017  Less than a ... hit more than 200,000 companies, including hospital networks, in ... heralded as one of the largest online extortion attempts ... the healthcare market, it is imperative that providers understand ... their data from this — and many other very ...
Breaking Medicine Technology: